No-Cost, No-Obligation New Hampshire Onglyza Lawsuit Review

Information about New Hampshire Onglyza Claims from Lawyers Handling Onglyza Lawsuits in New Hampshire

New Hampshire Onglyza Attorneys

New Hampshire Onglyza Lawsuits - Lawyers Handling Onglyza Heart Failure Lawsuits Offer No-Cost, No-Obligation Onglyza Case Review to Residents of New Hampshire

New Hampshire Residents: Information about Onglyza Heart Attack from Onglyza Lawyers for New Hampshire

New Hampshire Onglyza Heart Disease Lawsuit

Onglyza (saxagliptin), a popular drug used to regulate blood glucose levels in patients with Type II diabetes, has been linked to an increased risk for heart failure, heart attack and heart disease. Based on research showing patients taking Onglyza are hospitalized for heart failure more often than diabetics not taking Onglyza, the FDA added an Onglyza heart failure warning to the product’s label in April of 2016.

Cardiac risks such as heart disease, heart attack and heart failure from Onglyza were the subject of an FDA Endocrinologic and Metabolic Drugs Advisory Committee meeting in 2015. Onglyza was first approved for use in the United States in 2009. Believing it to be safe, patients who have taken the drug since 2009 have been exposed to an increased risk for heart failure from Onglyza at no fault of their own.

Unaware of the potential for cardiovascular problems such as heart attack or heart failure from Onglyza, doctors and patients have come to favor the drug for its effectiveness in regulating blood glucose levels and because it does not result in weight gain (a typical side effect of other glucose regulators). Marketed by the British-Swedish pharmaceutical company AstraZeneca, Onglyza sales garnered $786 million in 2015. Prior to the announcement of the April 2016 FDA Onglyza heart failure warning, the drug had been projected to yield annual sales of $2.47 billion by 2018. AstraZeneca has been aware of the connection between Onglyza and heart problems since 2013 but did not warn consumers of the potential danger until required to do so by the FDA in 2016.

If you or a loved one in New Hampshire has suffered from heart failure, heart attack, or heart disease, you may be eligible to receive compensation through filing a New Hampshire Onglyza lawsuit. Attorneys handling New Hampshire Onglyza heart attack lawsuits provide free, no-obligation Onglyza case review to individuals and family members of persons in New Hampshire who match this description. These New Hampshire Onglyza attorneys are leaders in the realm of pharmaceutical and product liability litigation, holding large corporations accountable for the harm dangerous drugs have exacted against innocent consumers.


Onglyza Heart Disease Info for New Hampshire

Onglyza Heart Failure Information for Residents of New Hampshire

Recent research indicates Onglyza increases the risk of heart attack, heart disease, and heart failure. In a large, randomized study, patients taking Onglyza were hospitalized for heart failure 1.27 times more frequently than diabetics not taking the drug. Heart attack, heart failure, heart disease and death are all risks for patients taking Onglyza in New Hampshire. Read current Onglyza heart research and risk information from attorneys handling New Hampshire Onglyza heart attack and failure lawsuits.


FDA Onglyza Warning Info for New Hampshire

FDA Onglyza Warning Information for Residents of New Hampshire

In April of 2016, the FDA Onglyza Warning was released which cautions doctors and patients of the increased risk of heart failure from Onglyza. While the drug is still widely used in the United States, the FDA Onglyza warning brings new information about Onglyza heart disease and heart attack risks. Read full FDA Onglyza warning information from attorneys for New Hampshire.


New Hampshire Onglyza Lawsuit

New Hampshire Onglyza Lawsuits

Individuals and family members of persons in New Hampshire who have suffered from Onglyza heart disease or heart attack may be entitled to compensation through filing New Hampshire Onglyza lawsuits. Persons in New Hampshire meeting this description are eligible for a free, no-obligation case review from an experienced attorney handling Onglyza lawsuits in New Hampshire. Onglyza heart failure lawsuits against the drug maker AstraZeneca are being filed for persons in New Hampshire and nationwide. New Hampshire Onglyza lawsuit fees are contingent on outcome, meaning you pay nothing unless we win for you.


New Hampshire Onglyza Lawsuit FAQ

New Hampshire Onglyza Lawsuit FAQs

For persons who believe they may have grounds to file an Onglyza heart disease lawsuit in New Hampshire, this page offers answers to commonly asked New Hampshire Onglyza lawsuit questions. Frequently asked New Hampshire Onglyza lawsuit questions include, How much does it cost to file an Onglyza lawsuit for heart attack in New Hampshire? and Are there time limits on filing a New Hampshire Onglyza lawsuit claim? Read for full answers to New Hampshire Onglyza Lawsuit FAQs compiled by attorneys handling Onglyza heart lawsuit claims in New Hampshire.


New Hampshire Onglyza Attorneys

New Hampshire Onglyza Attorneys

Our Onglyza lawyers for New Hampshire are experienced in achieving justice for consumers harmed by large pharmaceutical corporations. Backed by extensive experience, a strong track record of success, and the significant resources that come only with a leading national drug safety law firm, these New Hampshire Onglyza attorneys are equipped to handle the complexities of your claim, whatever they may be. An New Hampshire Onglyza attorney is available to discuss your case without fee or obligation and there are never any legal fees unless we collect for you.